|
CAPZB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.463100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.777900E-02 |
| Normal-vs-Stage2 |
6.490200E-01 |
| Normal-vs-Stage3 |
3.705500E-02 |
| Normal-vs-Stage4 |
2.235200E-04 |
| Stage1-vs-Stage2 |
4.556400E-01 |
| Stage1-vs-Stage3 |
5.796800E-01 |
| Stage1-vs-Stage4 |
6.638900E-03 |
| Stage2-vs-Stage3 |
2.965600E-01 |
| Stage2-vs-Stage4 |
1.088400E-02 |
| Stage3-vs-Stage4 |
2.932300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.117300E-03 |
| Normal-vs-AfricanAmerican |
2.616600E-01 |
| Normal-vs-Asian |
2.408800E-01 |
| Caucasian-vs-AfricanAmerican |
5.773400E-01 |
| Caucasian-vs-Asian |
5.126200E-01 |
| AfricanAmerican-vs-Asian |
4.149400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.889520E-02 |
| Normal-vs-Female |
2.076400E-03 |
| Male-vs-Female |
3.196400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.675910E-02 |
| Normal-vs-Age(41-60Yrs) |
4.436100E-04 |
| Normal-vs-Age(61-80Yrs) |
8.565800E-02 |
| Normal-vs-Age(81-100Yrs) |
5.605400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.295000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.367640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.480200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.388500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.140300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.727630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.155900E-02 |
| Normal-vs-Grade 2 |
4.165800E-02 |
| Normal-vs-Grade 3 |
1.280420E-01 |
| Normal-vs-Grade 4 |
2.78269999998138E-06 |
| Grade 1-vs-Grade 2 |
4.187200E-01 |
| Grade 1-vs-Grade 3 |
3.814400E-01 |
| Grade 1-vs-Grade 4 |
1.059970E-01 |
| Grade 2-vs-Grade 3 |
6.727800E-01 |
| Grade 2-vs-Grade 4 |
3.423800E-04 |
| Grade 3-vs-Grade 4 |
1.977390E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.817000E-01 |
| Normal-vs-ccB subtype |
1.716630E-03 |
| ccA subtype-vs-ccB subtype |
4.399900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.769900E-02 |
| Normal-vs-N1 |
1.655630E-03 |
| N0-vs-N1 |
1.540620E-03 |
|
|
